Atlas FDA

Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account

Aju Pharm Co., Ltd. — Predicate Candidate Screening

10 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.

232 daysmedian FDA review time
445 days90th percentile
10clearances measured
K-numberDeviceApplicantDecidedReview daysRecalls (K-match)
K233601Fixone Meniscal RepairAju Pharm Co., Ltd.2024-08-022678
K230892Fixone Biocomposite AnchorAju Pharm Co., Ltd.2023-06-09708
K222423Fixone All Suture AnchorAju Pharm Co., Ltd.2023-03-232248
K203523Fixone hybrid knotless anchorAju Pharm Co., Ltd.2021-12-253898
K193497Fixone Biocomposite Interference ScrewAju Pharm Co., Ltd.2021-01-053858
K192709Fixone All Suture AnchorAju Pharm Co., Ltd.2020-12-154450
K192484Fixone Biocomposite AnchorAju Pharm Co., Ltd.2020-03-111830
K192032Fixone Biocomposite Small AnchorAju Pharm Co., Ltd.2020-03-032170
K171299Fixone Biocomposite AnchorAju Pharm Co., Ltd.2017-08-241130
K162070JOINIX CANNULAR SYSTEMAju Pharm Co., Ltd.2017-03-162320

Methodology

Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.

Prepared with Atlas

Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda